Close

Articles Posted in Ethicon

Updated:

J&J Ethicon Hammered for $3.27M in Trans Vaginal Mesh Trial

A federal jury in West Virginia today hammered Johnson and Johnson’s Ethicon subsidiary over its transvaginal mesh device. The jury awarded $3.27 million to Jo Huskey over its defective Gynecare TVT Obturator, or TVT-O, transvaginal mesh device. This is one of 33,000 product liability injury lawsuits that claim Johnson &…

Updated:

Boston Scientific Wins 2nd Trans Vaginal Mesh Lawsuit

According to a Massachusetts jury, Boston Scientific’s vaginal-mesh sling was not defectively designed and the company properly warned about its health risks. This verdict marks a second victory for the company in two state trials over the vaginal mesh inserts. Jurors in state court in Woburn, Massachusetts, cleared Boston Scientific…

Updated:

Endo AMS Settles Vaginal-Mesh Injuries Lawsuits

Endo Health Solutions Inc., said it will pay about $830 million to settle most transvaginal lawsuits. Thousands of injured women allege that its vaginal-mesh implants eroded, left them incontinent and made sex painful. Endo’s American Medical Systems Inc. unit reported that it’s settling about 20,000 law suit product liability injury…

Updated:

J&J Ethicon Trans Vaginal Mesh MDL Trial Set For August

Johnson & Johnson and its Ethicon subsidiary are exposed to more than 17,500 Ethicon pelvic mesh lawsuits in the federal court system. Thousands of injured women have filed Ethicon Gynecare mesh product liability lawsuits for transvaginal repair, pelvic organ prolapse (POP) and female stress urinary incontinence (SUI) damage symptoms after…

Updated:

J & J Ethicon Stops Hysterectomy Power Morcellators Over Cancer Risk

Johnson & Johnson’s Ethicon subsidiary has announced that it will stop selling its power morcellators used for uterine fibroid removal surgery. Medical research has shown that use of the devices during minimally invasive laparoscopic hysterectomy and myomectomy procedures may carry a risk of spreading sarcoma cancer. Johnson & Johnson Ethicon:…

Updated:

FDA: Reclassification of Trans Vaginal Mesh as High Risk Device

The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify surgical mesh for transvaginal POP from a moderate-risk device (class II) to a high-risk device…

Updated:

F.D.A. Warns About Hysterectomy Morcellator Procedure

According to the FDA, doctors should stop using a procedure performed on thousands of American women a year in the course of hysterectomy uterine surgery, because it increases the risk of spreading cancerous tissue. The procedure, power morcellation, cuts uterine tissue into pieces that can be pulled out through the…

Updated:

J&J Loses Texas Transvaginal Mesh Incontinence Sling Lawsuit

Good news for Transvaginal mesh and sling plaintiffs and it’s more bad news for Johnson and Johnson’s (J&J) Ethicon division in its ongoing vaginal mesh debacle. The company will have to pay out again, in these many cases to go to court over its allegedly defective transvaginal mesh products and…

Updated:

Coloplast Settles Vaginal Mesh Lawsuits

According to confidential sources and a news report in Bloomberg, Coloplast A/S, has agreed to pay about $16 million to settle its transvaginal mesh lawsuits. Injured women who were implanted with the Danish mesh manufacturer’s vaginal-mesh inserts had filed personal injury claims against the company. The Denmark-based Coloplast agreed in…

Updated:

Report: J&J Ethicon Vaginal Mesh Company Destroyed Crucial Files

Injured women who have alleged product liability vaginal mesh lawsuits against Johnson & Johnson subsidiary Ethicon, have also filed a motion for sanctions. This motion claims that the manufacturer has destroyed a massive amount of data that was relevant to the litigation. Allegedly Ethicon destroyed or lost hundreds of thousands…

Contact Us
Start Chat